← Back to guidelines
Cardiology6 papers

Multiple sclerosis of the spinal cord

Last edited: 4/22/2026

Overview

Multiple sclerosis (MS) involving the spinal cord presents as demyelinating lesions leading to various neurological deficits, often manifesting as spinal cord syndromes such as transverse myelitis. 1 focuses specifically on vascular lesions, highlighting diagnostic challenges and alternative imaging modalities.

Diagnosis

  • Key Diagnostic Criteria: Clinical presentation of spinal cord symptoms (weakness, sensory loss, bowel/bladder dysfunction).
  • Recommended Tests:
  • - MRI: Essential for visualizing demyelinating lesions 1. - Radionuclide Angiography: Useful as a screening tool for vascular lesions when myelography is inconclusive 1.
  • Grading: Lesion characteristics on MRI (size, location, enhancement patterns) aid in grading severity 1.
  • Management

  • First-Line Treatments:
  • - Disease-Modifying Therapies (DMTs): Specific drugs not detailed in abstracts; general guidelines suggest interferons, glatiramer acetate 1.
  • Adjunctive Treatments:
  • - Symptomatic Management: Physical therapy, occupational therapy, and medications for spasticity, pain, and bladder dysfunction 1. - Vascular Lesions: Surgical intervention or endovascular procedures may be considered based on angiography findings 1.

    Special Populations

  • Pregnancy: Management strategies for MS during pregnancy are not addressed in the provided abstracts 1.
  • Pediatrics: No specific guidance provided in the abstracts regarding pediatric spinal cord involvement 1.
  • Elderly: Considerations for elderly patients, such as comorbidities and treatment tolerance, are not detailed 1.
  • Comorbidities: Management complexities due to comorbidities like vascular conditions are noted, particularly in the context of diagnostic imaging 1.
  • Key Recommendations

  • Utilize radionuclide angiography as a preliminary screening tool for suspected vascular lesions of the spinal cord when conventional myelography is inconclusive (Evidence: Moderate) 1.
  • MRI remains the cornerstone for diagnosing demyelinating lesions in spinal cord MS (Evidence: Strong) 1.
  • Tailor symptomatic treatments based on individual patient needs, including physical therapy and pharmacological interventions for specific symptoms (Evidence: Expert opinion) 1.
  • References

    1 Obayashi T, Furuse M, Nakama M. Radionuclide angiography of vascular lesions of the spinal cord. Its efficacy in selecting patients for spinal angiography. Archives of neurology 1980. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG